DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Zinman B, Wanner C, Lachin JM. , et al; EMPA-REG OUTCOME Investigators.
Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes.
N Engl J Med 2015;
373 (22) 2117-2128
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.